Evidence map›Paper›PMID 41756383›Full record

ArticleFrontiers in medicine2026

Novel non-antibiotic triple therapy for

Canyu Zhan, Yurong Huang, Zhengyi Yang, Hua Wu, Juan Zheng, Wangliu Yang, Junjie Rao, Gengqing Song, Jie Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Canyu Zhan *Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Yurong Huang *Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Zhengyi YangDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Hua WuDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Juan ZhengDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Wangliu YangDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Junjie RaoDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Gengqing SongDepartment of Gastroenterology and Hepatology, Metrohealth Medical Center, Case Western Reserve University, Cleveland, OH, United States.
Jie YangDepartment of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The rising antibiotic resistance has significantly reduced the efficacy of standard bismuth-based quadruple therapy for Patients and methods: A two-center retrospective analysis involved 48 FD patients who had previously failed at least two Results: Successful Conclusion: This study provides preliminary evidence supporting the use of non-antibiotic triple therapy as an alternative for managing

Indexed as

berberine hydrochlorideClostridium butyricumfunctional dyspepsiaHelicobacter pylorinon-antibiotic therapyWeisu granules

Identifiers

PMID41756383
PMCPMC12932454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.